Furthermore, while beta-actin antibody, one of several cytoskeletal antibodies grouped as anti-smooth muscle (SMA) antibody, is often associated with autoimmune hepatitis, however, the risk of cancer development in these patients is more skewed to hepatocellular carcinoma than breast cancer (84). Here, ACTB is linked to hepatocellular carcinoma.